Comparison of Bendroflumethiazide Oral Suspension and Salures Tablets

• Research type

  Research Study

• Full title

  An open label, randomised, two-period, two-sequence single dose crossover study to determine the comparative bioavailability of bendroflumethiazide oral suspension and the reference product, Salures® tablets, in healthy male and female volunteers.

• IRAS ID

  139383

• Contact name

  Girish Sharma

• Contact email

  girish.sharma@simbec.co.uk

• Sponsor organisation

  Essential Pharmaceuticals Ltd

• Eudract number

  2013-003004-39

• ISRCTN Number

  To be registered

• REC name

  Wales REC 2

• REC reference

  13/WA/0296

• Date of REC Opinion

  23 Oct 2013

• REC opinion

  Further Information Favourable Opinion